Literature DB >> 32097467

Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation.

Cornelius Pauli1,2, Yi Liu1, Christian Rohde1,3, Chunhong Cui1, Daria Fijalkowska4, Dennis Gerloff5, Carolin Walter6, Jeroen Krijgsveld4, Martin Dugas6, Bayram Edemir2, Caroline Pabst1,3, Lutz P Müller2, Fengbiao Zhou1, Carsten Müller-Tidow1,3.   

Abstract

Noncoding RNAs, including small nucleolar RNAs (snoRNAs), play important roles in leukemogenesis, but the relevant mechanisms remain incompletely understood. We performed snoRNA-focused CRISPR-Cas9 knockout library screenings that targeted the entire snoRNAnome and corresponding host genes. The C/D box containing SNORD42A was identified as an essential modulator for acute myeloid leukemia (AML) cell survival and proliferation in multiple human leukemia cell lines. In line, SNORD42A was consistently expressed at higher levels in primary AML patient samples than in CD34+ progenitors, monocytes, and granulocytes. Functionally, knockout of SNORD42A reduced colony formation capability and inhibited proliferation. The SNORD42A acts as a C/D box snoRNA and directs 2'-O-methylation at uridine 116 of 18S ribosomal RNA (rRNA). Deletion of SNORD42A decreased 18S-U116 2'-O-methylation, which was associated with a specific decrease in the translation of ribosomal proteins. In line, the cell size of SNORD42A deletion carrying leukemia cells was decreased. Taken together, these findings establish that high-level expression of SNORD42A with concomitant U116 18S rRNA 2'-O-methylation is essential for leukemia cell growth and survival.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32097467     DOI: 10.1182/blood.2019004121

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.

Authors:  Yue Zhuo; Shujun Li; Wei Hu; Yu Zhang; Yufan Shi; Faxue Zhang; Jian Zhang; Juan Wang; Meijuan Liao; Jiahao Chen; Huiling Qian; Dejia Li; Chengcao Sun
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

Review 2.  Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.

Authors:  Amr R Elhamamsy; Brandon J Metge; Heba A Alsheikh; Lalita A Shevde; Rajeev S Samant
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

3.  Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation.

Authors:  Junnan Liang; Ganxun Li; Jingyu Liao; Zhao Huang; Jingyuan Wen; Yu Wang; Zeyu Chen; Guangzhen Cai; Weiqi Xu; Zeyang Ding; Huifang Liang; Pran K Datta; Liang Chu; Xiaoping Chen; Bixiang Zhang
Journal:  Cell Death Differ       Date:  2022-01-15       Impact factor: 12.067

Review 4.  RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases.

Authors:  Amber Willbanks; Shaun Wood; Jason X Cheng
Journal:  Genes (Basel)       Date:  2021-04-22       Impact factor: 4.096

Review 5.  Regulation of Ribosome Function by RNA Modifications in Hematopoietic Development and Leukemia: It Is Not Only a Matter of m6A.

Authors:  Francesco Fazi; Alessandro Fatica
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 6.  Small nucleolar RNA is potential as a novel player in leukemogenesis and clinical application.

Authors:  Li-Min Lin; Qi Pan; Yu-Meng Sun; Wen-Tao Wang
Journal:  Blood Sci       Date:  2021-10-19

Review 7.  The role of OncoSnoRNAs and Ribosomal RNA 2'-O-methylation in Cancer.

Authors:  Daniela Barros-Silva; Jonathan Klavert; Guido Jenster; Carmen Jerónimo; Denis L J Lafontaine; Elena S Martens-Uzunova
Journal:  RNA Biol       Date:  2021-11-14       Impact factor: 4.652

Review 8.  The Potential Role of Small Nucleolar RNAs in Cancers - An Evidence Map.

Authors:  Fanqi Wu; Longguo Zhang; Pingfan Wu; Yi Wu; Tao Zhang; Dekui Zhang; Jinhui Tian
Journal:  Int J Gen Med       Date:  2022-04-08

Review 9.  snoRNAs: functions and mechanisms in biological processes, and roles in tumor pathophysiology.

Authors:  Zheng-Hao Huang; Yu-Ping Du; Jing-Tao Wen; Bing-Feng Lu; Yang Zhao
Journal:  Cell Death Discov       Date:  2022-05-12

10.  Constitutive and variable 2'-O-methylation (Nm) in human ribosomal RNA.

Authors:  Yuri Motorin; Marc Quinternet; Wassim Rhalloussi; Virginie Marchand
Journal:  RNA Biol       Date:  2021-09-10       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.